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Human fibroblasts, transfected with a recombinant DNA containing the neo gene and BK Virus (BKV) early region, which
expresses BKV large T antigen (TAg), show cytogenetic alterations characterized by dicentric chromosomes and other
structural aberrations such as deletions, duplications, translocations, and ring chromosomes. Such alterations were absent
or significantly less frequent in human fibroblasts transfected with a plasmid expressing only the neo gene. The chromosome
damage in BKV-transfected cells was evident before the appearance of the morphologically transformed phenotype and
therefore seems to be a primary effect of TAg expression in human cells. The specific pattern of chromosome aberrations
suggests the prevalence of an indirect clastogenic effect, determined by the inhibition of p53 regulatory functions on genome
stability by BKV TAg. Due to the widespread distribution of BKV in the human population and to the latent state of BKV DNA
in many human organs, the clastogenic activity of BKV TAg may potentially participate in an oncogenic process involving BKV
latently infected cells. © 1998 Academic Press
Carcinogenesis is a multifactorial and multiphase
process which involves the effects of chemical and
physical carcinogens and viruses. Clinical and exper-
imental observations indicate that chromosomal aber-
rations and karyotypic instability play a causal role in
the development and progression of tumors (1). The
immortalization and transformation of human cells in
culture is a rare event which requires the cooperation
of several factors, because human cells are subjected
to a process of replicative senescence (2) and show
an increased chromosome stability compared to ro-
dent cells (3). Herpesviruses, retroviruses, papovavi-
ruses, and adenoviruses are able to induce genetic
alterations in cells cultured in vitro (4–9). Cytogenetic
abnormalities have been described in human cells
immortalized by the papovavirus simian virus 40
(SV40) and it was shown that this chromosomal dam-
age is induced by SV40 large T antigen (TAg) (10, 11).
Moreover, the chromosomal alterations precede the
appearance of the immortalized phenotype, suggest-
ing that chromosome damage is the cause and not the
consequence of the immortalization process (10, 11).
BK virus (BKV) is a human papovavirus which is
ubiquitous in human populations and shows a world-
wide distribution (12). The primary infection, often
asymptomatic, is followed by a persistent, latent infec-
tion which is reactivated in immunosuppressed hosts
and sometimes in healthy individuals. BKV transforms
hamster, mouse, rat, rabbit, and monkey cells and is
highly oncogenic when inoculated into hamsters,
mice, and rats (13). Human cells can be immortalized
in vitro by BKV, BKV DNA, or BKV DNA fragments
containing the early region and expressing TAg (14).
BKV sequences have been detected in human brain
tumors, tumors of pancreatic islets, and normal human
tissues (15). BKV TAg, which is responsible for immor-
talization, transformation, and oncogenicity, induced
by BKV, has a 75% homology to SV40 TAg. Therefore, it
is reasonable that BKV TAg is also able to induce
chromosomal aberrations in human cells. In this study,
we report the results of a cytogenetic analysis of
human fibroblasts transfected with a recombinant
DNA containing BKV early region and expressing TAg.
Two types of human fibroblasts were used: human skin
embryonic fibroblasts (HEF) from a trisomic 21 fetus at the
16th week of gestation and the MRC-5 human diploid cell
strain, obtained from the European Collection of Animal
Cell Cultures (London, England). Cells were transfected
with pRPneoC, a plasmid containing BKV early region and
the neo gene (16), or with pSV2neo, a control plasmid
containing only the neo gene. HEF cells were transfected at
the 10th population doubling (p.d.), whereas MRC-5 cells
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were transfected at the 22nd p.d. Four to six weeks after
transfection, under selection with G418, colonies appeared
in cultures transfected with both pPRneoC and pSV2neo.
Colonies from MRC-5 cultures were dispersed together and
grown as mass cultures, whereas single HEF colonies
were picked and expanded in culture as individual clones.
Two clones transfected with pRPneoC (pRPneoCcl1 and
pRPneoCcl3) and two clones transfected with pSV2neo
(pSV2neocl3 and pSV2neocl4) were studied in detail for
their growth characteristics and karyotypic features.
FIG. 1. Morphological characteristics and BKV TAg staining of HEF cells transfected with pSV2neo and pRPneoC. (A) Normal HEF. (B) pSV2neocl3
cells. (C and D) pRPneoCcl1 and pRPneoCcl3 cells. (E) BKV TAg staining of pRPneoCcl1 cells. Normal HEF were observed at the 20th p.d., whereas
pSV2neocl3 cells as well as pRPneoCcl1 and pRPneoCcl3 cells were observed and stained for TAg at the 12th p.d. after transfection. Morphological
alterations, indicative of a transformed phenotype, begin to appear in cultures of pRPneoCcl1 and pRPneoCcl3 cells (C and D). Transfection with
pSV2neo and pRPneoC was performed by the calcium phosphate coprecipitation technique (14). Immunofluorescence for BKV TAg was carried out
as previously described (14) with hamster serum to BKV TAg and fluorescein-conjugated goat anti-hamster IgG (Antibodies Inc.).
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Cells from clones transfected with pPRneoC began to
appear more reflactile and to assume an epithelioid mor-
phology at the 12th p.d. after transfection and the morpho-
logically transformed phenotype was completely estab-
lished at the 15th p.d. after transfection, whereas cell clones
transfected with pSV2neo maintained a fibroblastic mor-
phology (Figs. 1A–D). Immunofluorescence staining indi-
cated that all the nuclei of pRPneoCcl1 and pRPneoCcl3
cells were positive for BKV TAg (Fig. 1E). Cell cultures of
normal HEF entered senescence at the 24th p.d. Likewise,
pSV2neocl3 and pSV2neocl4 cells entered senescence at
the 14th p.d. after transfection. On the contrary, pPRneoCcl1
and pRPneoCcl3 cells entered in a state of crisis at about
40 p.d. after transfection. Since HEF cells had been trans-
fected with pRPneoC and pSV2neo at the 10th p.d., the
expression of BKV TAg extended the lifespan of HEF cells
by about 25 p.d. The cloning efficiency on plastics was the
same (about 80 colonies/104 cells) for pRPneoCcl1 and
pRPneoCcl3 cells as well as for normal HEF cells and for
pSV2neocl3 and pSV2neocl4 cells. However, pRPneoCcl1
and pRPneoCcl3 cells produced colonies in agar (average
of 7 colonies/104 cells), whereas normal HEF cells and HEF
cells transfected by pSV2neo did not grow in semisolid
agar medium. PRPneoCcl1 and pRPneoCcl3 as well as
pSV2neocl3 and pSV2neocl4 did not produce tumors when
inoculated in nude mice (5 3 106 cells per animal) after an
observation period of 6 months. The presence and state of
pRPneoC DNA in pRPneoCcl1 and pRPneoCcl3 cells were
analyzed by Southern blot hybridization on cellular DNA
from the two clones digested with BamHI which cuts the
recombinant DNA at two sites, releasing two fragments of
8.6 and 2.6 kb, respectively. The hybridization pattern sug-
gested that a single integration of pRPneoC DNA is present
in each clone (Fig. 2). If pRPneoC DNA had integrated as an
FIG. 3. Representative features of the cytogenetic analysis of
pRPneoC DNA-transfected MRC-5 cells at the 6th population doubling
after transfection. The arrows indicate a chromosome gap (A), chromatid
breaks (B, C), dicentric chromosomes (C, E), and triradial figures (D). In E
the arrow at the right side of the figure indicates a dicentric chromosome
where the two centromeres appear very close, due to a process of centric
fusion. For cytogenetic analysis, cells were blocked in mitosis with
Colcemid (0.2 mg/ml) overnight and harvested by trypsinization. Cells were
then treated with a 0.075 M KCl solution for 20 min at 37°C and fixed
overnight in a mixture of ethanol:acetic acid (3:1). Metaphase spreads
were either stained in 5% Giemsa or subjected to G-banding by trypsin
using Giemsa staining (GTG) (26) and chromatin banding by barium
hydroxide treatment followed by Giemsa staining (CBG) (17). At least 15
metaphases were examined for each culture. Chromosome analysis was
performed with the computerized image analysis system Cytovision
(Nikon Instruments). Preparations in A–D were stained either with 5%
Giemsa or with GTG, whereas the preparation of E was stained by the
CBG method which is specific for the heterochromatin of centromeres and
most suitable to detect dicentric chromosomes.
FIG. 2. Southern blot hybridization of BamHI-digested total cellular
DNA (20 mg per lane) from pRPneoC-transfected HEF to a 32P-labeled
pRPneoC DNA probe. Lane 1, BamHI-cleaved pRPneoC DNA (5 ge-
nome equivalents). Lanes 2 and 3, pRPneoCcl1 and pRPneoCcl3 cel-
lular DNA. BamHI has two cleavage sites on pRPneoC and produces
two fragments of 8.6 and 2.6 kb.
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intact molecule into the host cell genome, one would ex-
pect, after digestion with BamHI, to detect a band comigrat-
ing with one of the bands of the control DNA (Fig. 2, lane 1).
Since this band is missing, it appears that pRPneoC DNA
has lost one BamHI site during integration in both cell
clones. However, this event does not affect the functional
integrity of BKV early region, because BKV TAg is ex-
pressed in essentially 100% of the cells in both cell clones
(Fig. 1E).
Cytogenetic analysis was initially performed on control
MRC-5 cells at the 28th p.d. and on pRPneoC DNA-trans-
fected MRC-5 cells at the 6th p.d. after transfection. Subse-
quently, the cytogenetic analysis was carried out in more
detail on untransfected HEF at the 20th p.d., and on
pSV2neocl3 and pSV2neocl4 at the 12th p.d. after transfec-
tion. pRPneoCcl1 and pRPneoCcl3 were analyzed at the 6th
and 9th p.d. after transfection, before the appearance of the
morphological modifications, as well as at the 15th p.d. after
transfection when the morphological transformed pheno-
type was established. The observation of MRC-5 cells in-
dicated that transfection with pRPneoC DNA significantly
increased chromosome abnormalities, since 25 dicentric
chromosomes (Fig. 3) out of 1228 chromosomes were
found in the transfected cells, while no dicentrics were
observed among 689 chromosomes in control MRC-5 cells
(P 5 1.6 3 1025). Other cytogenetic abnormalities, such as
gaps, breakages, triradial figures (Fig. 3), deletions, dupli-
cations, inversions, translocations, and acentric chromo-
somes, were observed in pRPneoC DNA-transfected
MRC-5 cells. HEF cells were examined in detail in order to
obtain more quantitative data on chromosome alterations
and to achieve informations about the mechanism of the
clastogenic effect observed in pRPneoC DNA-transfected
cells. As analytically reported in Table 1, the same chromo-
somal aberrations were observed in pRPneoC DNA-trans-
fected HEF cells. The chromosome damage was absent or
much less frequent in cell clones transfected with pSV2neo.
Statistical analysis (Fisher exact p test) showed a signifi-
cant increase of dicentric chromosomes and other struc-
tural aberrations in all HEFpRPneoC clones, when com-
pared with HEFpSV2neocl4, the clone displaying the high-
est frequency of cytogenetic abnormalities among controls,
whereas chromatid breaks and acentric fragments were
not constantly increased in the two pRPneoC-transfected
clones (Table 1). It is noteworthy that 68.6 to 100% of met-
aphases in the two HEFpRPneoC clones showed at least
one structural chromosomal abnormality, whereas met-
aphases with altered chromosomes ranged from 12.5 to
32.1% in pSV2neo-transfected clones.
Analysis of sister chromatid exchanges (SCEs) is a
very sensitive method for assaying DNA damage, used
to test chemical agents whose carcinogenic potential is
unknown. Large increases in the number of exchanges
occur with doses of mutagenic agents well below the
level needed to cause chromosome aberrations. The
technique involves two distinct steps: (1) incorporation of
bromodeoxyuridine into replicating DNA for two cell cy-
cles and (2) staining of chromosomes to detect the dif-
ference in BrdU content of DNA between the chromatids
(17). Only cells with a high mitotic index can be analyzed.
We were able to obtain SCE results only from BKV-
transfected cells: the observed frequency of SCEs was
6.4 per cell. Although it was not possible to compare this
result with a control of HEF cells, it seems to represent
a normal value considering that the number of SCEs in
different normal cells ranges from 2 to 20 with a mean
frequency between 5 and 8 (18).
In conclusion, the cytogenetic data clearly indicate an
increase of chromosomal structural aberrations in trans-
fected clones expressing BKV TAg. The pattern of chro-
mosomal alterations observed in human fibroblasts
transfected with BKV early region DNA is the same as
TABLE 1
Chromosome Abnormalities Observed in Normal and Transfected Cells
Cells Chromatid breaks Acentric fragments Dicentric chromosome Othersc
Normal HEF 20th p.d.a 3/751b 0/704 0/751 0/704
HEFpSV2neocl3 12th p.d. 5/1685 0/1496 0/1685 3/562
HEFpSV2neocl4 12th p.d.d 11/1313 0/1127 0/1313 0/187
HEFpRPneoCcl1 6th p.d. 32/823*** 5/823* 12/823*** 9/140***
HEFpRPneoCcl1 15th p.d. 25/1374* 7/1326* 34/1374*** 96/1326***
HEFpRPneoCcl3 9th p.d. 16/1631† 8/1536* 9/1631** 12/414*
HEFpRPneoCcl3 15th p.d. 12/1137† 2/959† 26/1137*** 63/959***
a p.d., total population doublings for normal HEF; population doublings after transfection for cells transfected by pSV2neo or pRPneoC.
b The fraction numerator represents the number of abnormal chromosomes observed; the denominator denotes the total number of chromosomes
analyzed.
c Other structural aberrations, not scored under the former categories (translocations, deletions, inversions, duplications, rings, triradial figures).
The lower number of chromosomes analyzed in some rows of the fourth column (others) is due to the loss of metaphases after restaining for GTG
banding the preparations previously examined by simple Giemsa staining for chromatid breaks, acentric fragments, and dicentric chromosomes.
d Statistical analysis was carried out by comparing pRPneoC-transfected clones with pSV2neocl4, the clone displaying the highest cumulative
frequency of chromosome aberrations among controls: *P , 5%; **P , 1%; ***P , 1‰; †not significant.
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that induced by SV40 TAg (10, 11). Therefore, owing to the
high homology between SV40 and BKV TAgs, this chro-
mosomal damage is most likely due to the expression of
BKV TAg. This conclusion is supported by the absence of
chromosomal alterations in cells transfected with a plas-
mid lacking BKV early region. The frequency of dicentric
chromosomes and of other structural aberrations in-
creases with p.d., suggesting that they are most probably
involved in the establishment of the immortalization pro-
cess and in progression of the transformed phenotype.
The mechanism of the clastogenic effect of BKV and
SV40 TAgs is not clear at present. It may reside in their
ability to bind topoisomerase I (19) and in their helicase
activity (20) which could induce chromosome damage
when unwinding the two strands of cellular DNA. More-
over, since BKV and SV40 TAgs bind the p53 protein (21)
inactivating its functions, the direct clastogenic effect of
these viral proteins may be enhanced, because they
inhibit p53-induced apoptosis and allow DNA damaged
cells to survive, increasing their probability of acquiring
immortality. The indirect clastogenic mechanism, based
on inactivation of p53 functions by BKV TAg, may be
prevalent in our experimental model. Indeed, the control
imposed by p53 should eliminate those cells bearing
simple chromosomal abnormalities, requiring only one
breakage such as chromatid breaks and acentric frag-
ments. On the contrary, we observe an increase of the
more consistent chromosome aberrations, such as di-
centric chromosomes, translocations, deletions, inver-
sions, and duplications which require two or more chro-
mosome breakages. This effect would be expected if p53
regulatory functions on genome stability fail, so that cells
with early genetic damage can progress through the cell
cycle and divide, accumulating more complex chromo-
some alterations. It is noteworthy that the same effect,
namely a marked increase of dicentric chromosomes
with p.d., was observed by Ray et al. (10) during the
analysis of the chromosomal aberrations induced by
SV40 TAg in human fibroblasts. In addition, the preva-
lence of an indirect effect on host cell chromosomes is
supported by the observation that SCEs, a relevant con-
sequence of direct clastogenic agents (18), were not
increased in pRPneoC DNA-transfected fibroblasts com-
pared to normal cells. It was previously shown that BKV
has a mutagenic activity for rodent and human cells (22).
The clastogenic and mutagenic activities of BKV may hit
genes that are crucial in oncogenesis, such as onco-
genes and tumor suppressor genes. Indeed, it has been
demonstrated that human chromosomes 6 and 11 con-
tain genes that arrest the in vitro growth of BKV-trans-
formed rodent cells or suppress the development of
tumors induced by these cells in nude mice (23, 24). BKV
is widespread in the human population (12) and is latent
in many organs of the human body (25). Therefore, the
expression of BKV TAg in host cells during the lifelong
period of latency may induce a chromosomal damage
responsible for the initiation or progression of an onco-
genic process involving BKV latently infected cells.
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